Rybrevant 350 MG/7 ML vial 7ML
Ended Awarded
- Contract number
- SPE2DR26FT882
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,254
Award facts
- Contract value 100% obligated
- $21,253.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Rybrevant 350 mg/7 ml vials at a ceiling value of $21,253.68. This firm fixed-price contract, with an ultimate completion date of December 8, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle through December 2026.
AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal healthcare vendor that supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The parent Indefinite Delivery Contract enables the company to furnish brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Rybrevant, an oncology treatment, reflects AmerisourceBergen's role in supporting the Department of Defense's pharmaceutical supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26FT882?
SPE2DR26FT882 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FT882 worth?
The government has obligated $21,254 on SPE2DR26FT882.
Is contract SPE2DR26FT882 an order under another contract?
Yes. SPE2DR26FT882 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT882 competed?
The extent of competition for SPE2DR26FT882 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award